Skip to content
  • Company
  • Product & Technology
  • Collaborations
  • News
  • Contact
2020-10-03

ExesaLiberoPharma was awarded a Phase II Small Business Technology

ExesaLiberoPharma was awarded a Phase II Small Business Technology Transfer (STTR) grant from the National Institute for Arthritis and Musculoskeletal Diseases (NIAMS) of the National Institutes of Health


© 2022 Copyright - ExesaLibero Pharma, Inc
FCOI Policy